✦ LIBER ✦

Phase I clinical study of nafazatrom

✍ Scribed by Gabriel N. Hortobagyi; Nicholas E.J. Papadoupoulos; Debra Frye; Jaffer Ajani; James M. Reuben

Publisher: Springer US
Year: 1986
Tongue: English
Weight: 341 KB
Volume: 4
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00179592

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A clinical study of nafazatrom in advanc

A clinical study of nafazatrom in advanced human breast cancer

✍ Alison L. Jones; Trevor J. Powles; Gary V. Forgeson; R. Charles Coombes 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 807 KB

Phase I and pharmacologic evaluation of

Phase I and pharmacologic evaluation of nafazatrom in patients with cancer

✍ Charles D. Haas; Laurence H. Baker; Llewelyn J. Evans 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 306 KB

Nafazatrom was evaluated in escalating daily oral doses ranging from 0.25 to 8.0 g/m 2 without producing significant toxicities. Malabsorption proved dose limiting at 8.0 g/m 2 as a single daily dose, but splitting the same total dose into two or four doses circumvented this problem. Doses of 2.0 g/

Phase I clinical and pharmacokinetic stu

Phase I clinical and pharmacokinetic study of LY 195448

✍ James Cassidy; Craig Lewis; Lynn Adams; Albert Setanoians; Martine Bayssas; Geor 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 446 KB

Angiogenic gene therapy: pre-clinical st

Angiogenic gene therapy: pre-clinical studies and phase I clinical data

✍ Bashir, Riyaz; Vale, Peter R.; Isner, Jeffrey M.; Losordo, Douglas W. 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 62 KB

Benznidazole with CCNU: A clinical phase

Benznidazole with CCNU: A clinical phase i toxicity study

✍ J.T. Roberts; N.M. Bleehen 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 472 KB

A phase I clinical study of nimorazole a

A phase I clinical study of nimorazole as a hypoxic radiosensitizer

✍ A.R. Timothy; J. Overgaard; M. Overgaard 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 351 KB